<DOC>
	<DOCNO>NCT00764114</DOCNO>
	<brief_summary>Duration antimicrobial therapy spondylodiscitis standardize ; could vary 6 week several month depend medical habit . The study hypothesis 6 week antimicrobial therapy inferior 12 week . We run prospective multi-centric , non inferiority open label trial , randomise two parallel group . The main objective compare efficacy two duration antibiotherapy , 6 week versus 12 week , rate cure indication . The study concern 400 patient 18 year , 70 centre France involve . The duration study 4 year .</brief_summary>
	<brief_title>Comparison Two Antimicrobial Therapy Duration Spondylodiscitis</brief_title>
	<detailed_description>In France , incidence spondylodiscitis 1000 1500 new case year . Micro-organisms mainly cause : Staphylococcus aureus , negative coagulase Staphylococcus , Gram negative bacillus Streptococci ; rarely mycobacteria Brucella . Actually , optimal duration antimicrobial therapy unclear . The rate cure varies , accord study , 90 100 % whatever responsible germ involve . If 6 week antimicrobial therapy duration inferior 12 , would allow shorten usual antimicrobial therapy duration , improve tolerance treatment , ecological economic benefit , follow politics good use antibiotic , define French circular nÂ°2002-272 02/05/02 . The main objective compare two duration antimicrobial therapy , 6 week versus 12 week , rate cure bacterial spondylodiscitis . Secondary objective compare , accord duration treatment antibiotic , 1 ) Rachidial pain clinical examination analogical visual scale ( EVA ) , 2 ) Quality life score EQ-5D , 3 ) Treatment tolerance . 4 ) Risk factor failure . Type study Prospective multi-centric , open label trial , randomise two parallel group direct individual profit . Antimicrobial therapy chosen physician charge patient accord germ consensual recommendation . The study concern 400 patient . Inclusion criterion : men woman 18 year , prove bacterial spondylodiscitis ( mycobacteria , fungal Brucella ) , antimicrobial therapy need ; woman age procreate use effective contraception protect sexual relation negative pregnancy test ( b HCG ) necessary . Non Inclusion criterion : infection bacteriological identification mycobacteria , fungal brucellosis infection , presence material recurrence spondylodiscitis . Main criterion evaluation : percentage success 1 year define absence infection : absence clinical , biological radiological sign infection ( pain , fever ) ; relapse germ . This criterion estimate beyond first 6 week treatment antibiotic introduction treatment 1 year stop treatment . The criteria bacteriological diagnosis . Design study : patient information consent sign include randomised one arm . They regularly follow ( 1 , 2 , 3 , 6 12 week begin antimicrobial therapy , 6 12 month end antimicrobial therapy ) , physical examination , biological test radiological act . The randomisation centralize , balance block , stratifies centre . ( 70 centre ) The previous duration study 4 year .</detailed_description>
	<mesh_term>Osteomyelitis</mesh_term>
	<mesh_term>Discitis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>men woman 18 year prove bacterial spondylodiscitis due pyogenic germ ( mycobacteria , fungus brucella ) , decide treatment antibiotic diagnosis base clinical , radiological microbiological criterion woman age procreate , use effective contraception protect sexual relation negative pregnancy test ( b HCG ) . infection bacteriological identification infection due mycobacteria , brucella fungus presence material recurrence spondylodiscitis Patient whose life expectation 1yearold subordinate pregnant breastfeeding Woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Spondylodiscitis</keyword>
	<keyword>Duration treatment</keyword>
	<keyword>Antibiotic</keyword>
	<keyword>men woman 18 year</keyword>
	<keyword>prove bacterial spondylodiscitis</keyword>
	<keyword>patient decide treatment antibiotic</keyword>
	<keyword>diagnosis clinical</keyword>
	<keyword>Radiological</keyword>
	<keyword>microbiological criterion</keyword>
</DOC>